Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Commissioning incoming packet switched connections
Image forming apparatus
Method and apparatus for receiving signals in a MIMO system with multiple channel encoders
Charge domain filter and method thereof
Sliding-type portable communication device
Synergistic fungicidal interactions of 5-fluorocytosine and other fungicides
  Randomly Featured Patents
Anti-wrinkle device
Method and apparatus on (110) surfaces of silicon structures with conduction in the <110> direction
Uniform coating method for light emitting diode
Control apparatus of air-conditioner
IP telephone terminal
Mission adaptive inlet
Cartons with reclosable opening features
Single deposition layer metal dynamic random access memory
Method and apparatus providing refractive index structure for a device capturing or displaying images
Interference canceller device and radio communication device